|
|||||
|
|
The heparin management test: a new device for monitoring anticoagulation during coronary intervention |
|
| Authors: | Helft G Bartolomeo P Zaman A G Worthley S G Chokron S Le Pailleur C Beygui F Le Feuvre C Metzger J P Vacheron A Samama M M |
| Affiliation: | 1 Clinique de Cardiologie, Hôpital Necker, Paris, France 2 Cardiovascular Institute–Mount Sinai Medical Center, New York, NY, USA 3 INSERM U324 Paris, France 4 LPE, CNRS, Grenoble, France 5 Service d'Hématologie Biologique, Hôtel-Dieu, Paris, France. |
| Abstract: | Whole blood coagulation analysers are widely used during percutaneous coronary interventions. The precise degree of anticoagulation in patients is important in this setting. The aim of this investigation was to compare the results obtained with ACT (Hemochron) and HMT, the Heparin Management Test (TAS) in patients undergoing percutaneous coronary interventions. Patients (n=100) were enrolled prospectively. Each patient received 10,000 units of heparin. At the end of the procedure, the mean ACT was 284±31 seconds and the mean HMT was 292±33 seconds. The correlation between the two methods was highly significant (r=0.64, p<0.001). The HMT correlates well with ACT values in patients undergoing percutaneous coronary interventions. Its use in the management of these patients should be considered. |
| Keywords: | Heparin Anticoagulation Coronary intervention |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |